ProPhase Labs, Inc. Operating Cash Flow
ProPhase Labs, Inc. (PRPH) reported Operating Cash Flow of -$826.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-19
- ProPhase Labs, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$78.00K.
- ProPhase Labs, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$748.00K.
- ProPhase Labs, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.23M.
- ProPhase Labs, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.49M.
- ProPhase Labs, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$8.34M.
- ProPhase Labs, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$17.54M.
- ProPhase Labs, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$11.89M, a 141.64% decline from fiscal 2022.
- ProPhase Labs, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $28.55M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-19 | -$826.00K 10-Q · filed 2026-08-19 | -$2.06M derived: sum of 3 quarters · filed 2026-08-19 | -$5.54M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | -$748.00K 10-Q/A · filed 2026-07-09 | -$1.98M derived: sum of 2 quarters · filed 2026-07-09 | -$5.46M derived: sum of 3 quarters · filed 2026-07-09 | -$5.71M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | -$4.72M derived: sum of 2 quarters · filed 2026-06-01 | -$4.96M derived: sum of 3 quarters · filed 2026-08-19 | -$8.34M 10-K · filed 2026-06-01 | ||||
| 2025-09-30 | -$3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$3.73M derived: sum of 2 quarters · filed 2026-08-19 | -$7.11M 10-Q · filed 2025-11-19 | -$10.63M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | -$247.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-19 | -$3.63M 10-Q · filed 2026-08-19 | -$7.15M derived: sum of 3 quarters · filed 2026-08-19 | -$11.18M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | -$3.38M 10-Q/A · filed 2026-07-09 | -$6.90M derived: sum of 2 quarters · filed 2026-07-09 | -$10.94M derived: sum of 3 quarters · filed 2026-07-09 | -$15.78M derived: sum of 4 quarters · filed 2026-07-09 | ||||
| 2024-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | -$7.56M derived: sum of 2 quarters · filed 2026-06-01 | -$12.40M derived: sum of 3 quarters · filed 2026-06-01 | -$17.54M 10-K · filed 2026-06-01 | ||||
| 2024-09-30 | -$4.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$8.88M derived: sum of 2 quarters · filed 2025-11-19 | -$14.02M 10-Q · filed 2025-11-19 | -$13.97M 10-Q · filed 2024-11-13 | -$14.77M derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | -$4.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$9.98M 10-Q · filed 2025-08-13 | -$9.94M 10-Q · filed 2024-08-14 | -$10.73M derived: sum of 3 quarters · filed 2025-08-13 | -$15.39M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | -$5.14M 10-Q · filed 2025-05-20 | -$5.12M 10-Q · filed 2024-05-10 | -$5.89M derived: sum of 2 quarters · filed 2025-05-20 | -$10.55M derived: sum of 3 quarters · filed 2025-05-20 | -$17.50M derived: sum of 4 quarters · filed 2025-05-20 | |||
| 2023-12-31 | -$753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | -$5.41M derived: sum of 2 quarters · filed 2025-04-01 | -$12.36M derived: sum of 3 quarters · filed 2025-04-01 | -$11.89M 10-K · filed 2025-04-01 | -$11.35M 10-K · filed 2024-03-29 | |||
| 2023-09-30 | -$4.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$11.61M derived: sum of 2 quarters · filed 2024-11-13 | -$11.13M 10-Q · filed 2024-11-13 | -$10.32M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$6.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$6.48M 10-Q · filed 2024-08-14 | -$5.67M derived: sum of 3 quarters · filed 2024-08-14 | -$3.04M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $476.00K 10-Q · filed 2024-05-10 | $1.29M derived: sum of 2 quarters · filed 2024-05-10 | $3.92M derived: sum of 3 quarters · filed 2024-05-10 | $8.74M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $811.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $3.44M derived: sum of 2 quarters · filed 2024-03-29 | $8.26M derived: sum of 3 quarters · filed 2024-03-29 | $28.55M 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $7.45M derived: sum of 2 quarters · filed 2023-11-13 | $27.74M 10-Q · filed 2023-11-13 | $23.09M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $25.11M 10-Q · filed 2023-08-11 | $20.46M derived: sum of 3 quarters · filed 2023-08-11 | $14.94M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $20.29M 10-Q · filed 2023-05-12 | $15.64M derived: sum of 2 quarters · filed 2023-05-12 | $10.12M derived: sum of 3 quarters · filed 2023-05-12 | $14.56M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$10.17M derived: sum of 2 quarters · filed 2023-03-29 | -$5.73M derived: sum of 3 quarters · filed 2023-03-29 | -$13.62M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | -$5.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.08M derived: sum of 2 quarters · filed 2022-11-10 | -$8.97M 10-Q · filed 2022-11-10 | -$15.74M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $4.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$3.45M 10-Q · filed 2022-08-12 | -$10.22M derived: sum of 3 quarters · filed 2022-08-12 | -$10.70M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$7.89M 10-Q · filed 2022-05-13 | -$14.66M derived: sum of 2 quarters · filed 2022-05-13 | -$15.14M derived: sum of 3 quarters · filed 2022-05-13 | -$10.77M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$7.25M derived: sum of 2 quarters · filed 2022-03-31 | -$2.88M derived: sum of 3 quarters · filed 2022-03-31 | -$2.59M 10-K · filed 2022-03-31 | $2.59M 10-K · filed 2021-03-31 | |||
| 2020-09-30 | -$481.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $3.89M derived: sum of 2 quarters · filed 2021-11-12 | $4.18M 10-Q · filed 2021-11-12 | $3.75M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $4.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $4.66M 10-Q · filed 2021-08-13 | $4.23M derived: sum of 3 quarters · filed 2021-08-13 | $3.34M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $285.00K 10-Q · filed 2021-05-14 | -$143.00K derived: sum of 2 quarters · filed 2021-05-14 | -$1.03M derived: sum of 3 quarters · filed 2021-05-14 | -$1.96M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$1.32M derived: sum of 2 quarters · filed 2021-03-31 | -$2.24M derived: sum of 3 quarters · filed 2021-03-31 | -$841.00K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | -$889.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-19 | -$1.82M derived: sum of 2 quarters · filed 2020-11-19 | -$413.00K 10-Q · filed 2020-11-19 | -$1.19M derived: sum of 4 quarters · filed 2020-11-19 | ||||
| 2019-06-30 | -$927.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $476.00K 10-Q · filed 2020-08-11 | -$305.00K derived: sum of 3 quarters · filed 2020-08-11 | -$1.61M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $1.40M 10-Q · filed 2020-05-12 | $622.00K derived: sum of 2 quarters · filed 2020-05-12 | -$679.00K derived: sum of 3 quarters · filed 2020-05-12 | -$550.00K derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | -$781.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$2.08M derived: sum of 2 quarters · filed 2020-03-26 | -$1.95M derived: sum of 3 quarters · filed 2020-03-26 | -$2.12M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$1.17M derived: sum of 2 quarters · filed 2019-11-12 | -$1.34M 10-Q · filed 2019-11-12 | -$3.06M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$37.00K 10-Q · filed 2019-08-12 | -$1.76M derived: sum of 3 quarters · filed 2019-08-12 | -$2.21M derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | -$166.00K 10-Q · filed 2019-05-14 | -$1.89M derived: sum of 2 quarters · filed 2019-05-14 | -$2.34M derived: sum of 3 quarters · filed 2019-05-14 | -$6.01M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$2.17M derived: sum of 2 quarters · filed 2019-03-26 | -$5.84M derived: sum of 3 quarters · filed 2019-03-26 | -$2.84M 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | -$445.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | -$4.12M derived: sum of 2 quarters · filed 2018-11-14 | -$1.11M 10-Q · filed 2018-11-14 | -$714.00K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | -$3.67M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | -$667.00K 10-Q/A · filed 2018-08-20 | -$269.00K derived: sum of 3 quarters · filed 2018-08-20 | -$951.00K derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2017-03-31 | $3.01M 10-Q/A · filed 2018-08-20 | $3.40M derived: sum of 2 quarters · filed 2018-08-20 | $2.72M derived: sum of 3 quarters · filed 2018-08-20 | $1.53M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2016-12-31 | $398.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | -$284.00K derived: sum of 2 quarters · filed 2018-08-20 | -$1.48M derived: sum of 3 quarters · filed 2018-08-20 | -$472.00K 10-K/A · filed 2018-08-20 | ||||
| 2016-09-30 | -$682.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-08-20 | -$1.87M derived: sum of 2 quarters · filed 2018-08-20 | -$870.00K 10-Q/A · filed 2018-08-20 | -$1.88M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2016-06-30 | -$1.19M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | -$188.00K 10-Q/A · filed 2018-08-20 | -$1.20M derived: sum of 3 quarters · filed 2018-08-20 | -$4.42M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2016-03-31 | $1.00M 10-Q/A · filed 2018-08-20 | -$9.00K derived: sum of 2 quarters · filed 2018-08-20 | -$3.22M derived: sum of 3 quarters · filed 2018-08-20 | -$4.63M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2015-12-31 | -$1.01M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | -$4.23M derived: sum of 2 quarters · filed 2018-08-20 | -$5.63M derived: sum of 3 quarters · filed 2018-08-20 | -$3.50M 10-K/A · filed 2018-08-20 | ||||
| 2015-09-30 | -$3.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$4.62M derived: sum of 2 quarters · filed 2016-11-14 | -$2.48M 10-Q · filed 2016-11-14 | -$4.22M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-06-30 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $730.00K 10-Q · filed 2016-08-11 | -$1.01M derived: sum of 3 quarters · filed 2017-02-24 | -$3.45M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-03-31 | $2.13M 10-Q · filed 2016-05-13 | $394.00K derived: sum of 2 quarters · filed 2017-02-24 | -$2.05M derived: sum of 3 quarters · filed 2017-02-24 | |||||
| 2014-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$4.18M derived: sum of 2 quarters · filed 2017-02-24 | -$3.22M 10-K · filed 2017-02-24 | |||||
| 2014-09-30 | -$2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$1.48M 10-Q · filed 2015-11-13 | ||||||
| 2014-06-30 | $964.00K 10-Q · filed 2015-08-12 | |||||||
| 2013-12-31 | $856.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$2.40M derived: sum of 2 quarters · filed 2016-03-29 | -$2.64M derived: sum of 3 quarters · filed 2016-03-29 | $1.14M 10-K · filed 2016-03-29 | ||||
| 2013-09-30 | -$3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$3.50M derived: sum of 2 quarters · filed 2013-11-13 | $281.00K 10-Q · filed 2013-11-13 | -$2.06M derived: sum of 4 quarters · filed 2013-11-13 | ||||
| 2013-06-30 | -$236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $3.54M 10-Q · filed 2013-08-13 | $1.21M derived: sum of 3 quarters · filed 2013-08-13 | -$1.49M derived: sum of 4 quarters · filed 2013-11-13 | ||||
| 2013-03-31 | $3.78M 10-Q · filed 2013-05-10 | $1.44M derived: sum of 2 quarters · filed 2013-05-10 | -$1.25M derived: sum of 3 quarters · filed 2013-11-13 | -$2.73M derived: sum of 4 quarters · filed 2013-11-13 | ||||
| 2012-12-31 | -$2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$5.03M derived: sum of 2 quarters · filed 2013-11-13 | -$6.50M derived: sum of 3 quarters · filed 2013-11-13 | -$5.73M 10-K · filed 2013-03-28 | ||||
| 2012-09-30 | -$2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$4.17M derived: sum of 2 quarters · filed 2013-11-13 | -$3.39M 10-Q · filed 2013-11-13 | -$2.46M derived: sum of 4 quarters · filed 2013-11-13 | ||||
| 2012-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$699.00K 10-Q · filed 2013-08-13 | $238.00K derived: sum of 3 quarters · filed 2013-08-13 | -$3.36M derived: sum of 4 quarters · filed 2013-08-13 | ||||
| 2012-03-31 | $775.00K 10-Q · filed 2013-05-10 | $1.71M derived: sum of 2 quarters · filed 2013-05-10 | -$1.88M derived: sum of 3 quarters · filed 2013-05-10 | -$2.53M derived: sum of 4 quarters · filed 2013-05-10 | ||||
| 2011-12-31 | $937.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$2.66M derived: sum of 2 quarters · filed 2013-03-28 | -$3.31M derived: sum of 3 quarters · filed 2013-03-28 | -$2.11M 10-K · filed 2013-03-28 | ||||
| 2011-09-30 | -$3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$4.24M derived: sum of 2 quarters · filed 2012-11-14 | -$3.04M 10-Q · filed 2012-11-14 | -$3.51M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-06-30 | -$649.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $549.00K 10-Q · filed 2012-08-13 | $83.00K derived: sum of 3 quarters · filed 2013-03-28 | -$2.35M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-03-31 | $1.20M 10-Q · filed 2012-05-11 | $732.00K derived: sum of 2 quarters · filed 2013-03-28 | -$1.70M derived: sum of 3 quarters · filed 2013-03-28 | |||||
| 2010-12-31 | -$466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$2.89M derived: sum of 2 quarters · filed 2013-03-28 | -$3.55M 10-K · filed 2013-03-28 | |||||
| 2010-09-30 | -$2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$3.08M 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$655.00K 10-Q · filed 2011-08-12 | |||||||
| 2009-12-31 | $445.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |